R. Besch

发表

SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.

C. Berking, A. Bosserhoff, S. Graf, 2014, The Journal of investigative dermatology.

Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.

S. Bavari, R. Panchal, B. Vasiljević, 2019, European journal of medicinal chemistry.

Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma

R. Bakos, D. Mestel, C. Berking, 2009, Experimental dermatology.

Melanocyte antigen triggers autoimmunity in human psoriasis

S. Krebs, M. Spannagl, J. Prinz, 2015, The Journal of experimental medicine.

5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I

A. Schmidt, S. Endres, T. Schwerd, 2009, Proceedings of the National Academy of Sciences.

Psoriatic Lesions Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in

V. Hornung, D. Anz, T. Ruzicka, 2011 .

The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival

C. Berking, S. Haferkamp, H. Hermeking, 2013, EMBO molecular medicine.

Entwicklung und Anwendung eines in vitro Co-Kultur-Modells der Haut zur Identifizierung potentieller Therapeutika bei Schwefellost-Vergiftungen Development and Application of a in vitro Co-Culture Model of the Skin for the Identificaton of Therapeutics against Sulfur Mustard Intoxications

T. Gudermann, O. Peschel, R. Besch, 2018 .

POU transcription factors in melanocytes and melanoma.

C. Berking, R. Besch, 2014, European journal of cell biology.

Protease Inhibitors Prevent Plasminogen-Mediated, But Not Pemphigus Vulgaris-Induced, Acantholysis in Human Epidermis

M. Flaig, V. Magdolen, C. Sander, 2003, Biological chemistry.

This information is current as by Regulatory T Cells Immunostimulatory RNA Blocks Suppression

V. Hornung, G. Hartmann, S. Endres, 2009 .

Specific Inhibition of ICAM-1 Expression Mediated by Gene Targeting with Triplex-forming Oligonucleotides*

C. Giovannangeli, R. Besch, K. Degitz, 2002, The Journal of Biological Chemistry.

IL-17A Enhances Vitamin D3-Induced Expression of Cathelicidin Antimicrobial Peptide in Human Keratinocytes1

T. Ruzicka, R. Gallo, J. Prinz, 2008, The Journal of Immunology.

Differential expression of melanoma‐associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation

C. Berking, R. Besch, K. Degitz, 2005, The British journal of dermatology.

Characterization and quantification of triple helix formation in chromosomal DNA.

C. Giovannangeli, R. Besch, K. Degitz, 2004, Journal of molecular biology.

Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1

G. Häcker, N. Zantl, R. Besch, 2010, Molecular Cancer.

Cytosolic DNA Triggers Mitochondrial Apoptosis via DNA Damage Signaling Proteins Independently of AIM2 and RNA Polymerase III

A. Schmidt, M. Wunderlich, G. Sutter, 2012, The Journal of Immunology.

The spectrum of Malassezia species isolated from students with pityriasis vesicolor in Nigeria

T. Ruzicka, R. Besch, M. Sárdy, 2015, Mycoses.

In vitro inhibition of Cyprinid herpesvirus-3 replication by RNAi

M. El-Matbouli, R. Besch, H. Soliman, 2014, Journal of virological methods.

SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.

C. Berking, R. Sturm, T. Maier, 2009, The Journal of investigative dermatology.

Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53

C. Berking, R. Besch, K. Degitz, 2007, Cell Death and Differentiation.

Immunostimulatory RNA Blocks Suppression by Regulatory T Cells

V. Hornung, G. Hartmann, S. Endres, 2009, The Journal of Immunology.

Inhibition of spring viraemia of carp virus replication in an Epithelioma papulosum cyprini cell line by RNAi

M. El-Matbouli, R. Besch, H. Soliman, 2014, Journal of fish diseases.

Triplex-forming oligonucleotides - sequence-specific DNA ligands as tools for gene inhibition and for modulation of DNA-associated functions.

Carine Giovannangeli, C. Giovannangeli, R. Besch, 2004, Current drug targets.

Triple helix-mediated inhibition of gene expression is increased by PUVA.

C. Giovannangeli, R. Besch, K. Degitz, 2004, The Journal of investigative dermatology.

Targeting the Cytosolic Innate Immune Receptors RIG‐I and MDA5 Effectively Counteracts Cancer Cell Heterogeneity in Glioblastoma

J. Mertens, R. Fimmers, H. Neumann, 2013, Stem cells.

The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil

R. Bakos, C. Berking, L. Bakos, 2011, Experimental dermatology.

MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression.

C. Berking, M. Herlyn, Zhi Wei, 2018, The Journal of investigative dermatology.

Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions

V. Hornung, D. Anz, T. Ruzicka, 2011, Science Translational Medicine.

Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells

G. Häcker, M. Leverkus, R. Besch, 2010, Cell Death and Differentiation.

Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.

C. Berking, V. Hornung, G. Hartmann, 2009, The Journal of clinical investigation.

This information is current as Polymerase III Proteins Independently of AIM 2 and RNA Apoptosis via DNA Damage Signaling Cytosolic DNA Triggers Mitochondrial

M. Wunderlich, S. Endres, S. Rothenfusser, 2011 .

HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma

C. Berking, M. Heppt, A. Bosserhoff, 2022, International journal of molecular sciences.

A Bifunctional Approach of Immunostimulation and uPAR Inhibition Shows Potent Antitumor Activity in Melanoma.

C. Berking, M. Heppt, A. Aigner, 2016, The Journal of investigative dermatology.

5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma

Svetlana Shulga Morskaya, C. Berking, M. Neuenhahn, 2008, Nature Medicine.

Gene Therapy for Advanced Melanoma: Selective Targeting and Therapeutic Nucleic Acids

M. Ogris, E. Wagner, D. Rafael, 2013, Journal of drug delivery.

Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1

C. Berking, T. Ruzicka, D. Senft, 2012, PloS one.

Bifunctional siRNAs for tumor therapy.

R. Besch, Fanny Matheis, 2014, Methods in molecular biology.

In non-transformed cells Bak activates upon loss of anti-apoptotic Bcl-XL and Mcl-1 but in the absence of active BH3-only proteins

C. Berking, G. Häcker, S. Kellner, 2015, Cell Death and Disease.

Expression of BRN2, osteopontin and nestin in melanoma and nevi. New markers of tumor progression?

D. Mestel, C. Berking, U. Nagele, 2006 .

MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression.

C. Berking, M. Herlyn, Zhi Wei, 2018, Journal of Investigative Dermatology.

Specific Inhibition of ICAM-1 Expression Mediated by Gene Targeting with Triplex-forming Oligonucleotides*

C. Giovannangeli, R. Besch, K. Degitz, 2002, The Journal of Biological Chemistry.